Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease is increasing in prevalence. It can be subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Five to twenty percent of cases progress from NAFL to NASH. Increased hepatic Th17 cells and IL-17 expression were observed in NASH mice and patients, respectively. We analyzed CD4+ effector T cells and regulatory T cells (Tregs) from peripheral blood and livers of NAFL and NASH patients. A total of 51 NAFL patients, 30 NASH patients, 31 nonalcoholic fatty liver disease patients (without histology), and 43 healthy controls were included. FACS analysis was performed on PBMCs and intrahepatic lymphocytes. Compared with healthy controls, a lower frequency of resting Tregs (rTregs; CD4+CD45RA+CD25++) and higher frequencies of IFN-γ+ and/or IL-4+ cells were detected among CD4+ T cells of peripheral blood in NASH, and to a lesser degree in NAFL. In hepatic tissue, NAFL to NASH progression was marked by an increase in IL-17+ cells among intrahepatic CD4+ T cells. To define immunological parameters in peripheral blood to distinguish NAFL from NASH, we calculated different ratios. Th17/rTreg and Th2/rTreg ratios were significantly increased in NASH versus NAFL. The relevance of our findings for NASH pathogenesis was highlighted by the normalization of all of the changes 1 y after bariatric surgery. In conclusion, our data indicate that NAFL patients show changes in their immune cell profile compared with healthy controls. NAFL to NASH progression is marked by an increased frequency of IL-17+ cells among intrahepatic CD4+ T cells and higher Th17/rTreg and Th2/rTreg ratios in peripheral blood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with similar trends in CCL5+HOPX+ TH1 cells in both compartments and RTKN2+CCR7lo memory Treg cells in the liver (Fig. 5g)”
In the citing paper
“we observed a positive correlation of CD45RO+SELLhi CD4+ TCM cells and KLRB1+RORC+ TH17 cells in both liver and blood with fibrosis”
In the citing paper
“We found a marked increase in proinflammatory TH1 cell and TH17 cell frequency and function with MASH in the liver and peripheral blood, consistent with previous reports32,33, alongside an increase in RTKN2+CCR7lo memory Treg cells”
In the citing paper
“CD4 + T H 17 cells and CD8 + T cells have been shown to mediate NASH-associated liver fibrosis in both mice and humans (5-9).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [8]
Citations
Cites
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 1×
“whereas TGF-b alone induces Tregs instead of Th17 cells (6, 7).”
BackgroundAngulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203 · cited 1×
“3 (13) Elevated alkaline phosphatase (% [n]) 9.”
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110 · cited 1×
“Eight-one patients had histology-proven NAFL or NASH, and 31 patients were diagnosed with NAFLD by typical ultrasound findings, as described by sonographic NASH score (11).”
MethodThe Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700 · cited 4×
“The inflammatory process underlying NASH is characterized by elevated expression of inflammatory cytokines, such as TNF-a and IL-6.”
InfluentialBrunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251
Standardizing immunophenotyping for the Human Immunology Project
Maecker, H. T., McCoy, J. P., & Nussenblatt, R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3158 · Cited by 1,176 · cited 1×
“To determine whether the liver-infiltrating T cells are recently activated cells, we stained for HLA-DR expression (19).”
BackgroundLi, M. O., Sanjabi, S., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.011 · Cited by 805
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease
Gadd, V. L., Skoien, R., Powell, E. E., Fagan, K. J., Winterford, C., Horsfall, L., Irvine, K., & Clouston, A. D. (2014) · Hepatology · doi:10.1002/hep.26937 · Cited by 452 · cited 1×
“Cells expressing several T cell markers were recently identified by immunostaining in NAFLD liver biopsy sections (20).”
BackgroundThe interleukin-17 pathway is involved in human alcoholic liver disease # †
Lemmers, A., Moreno, C., Gustot, T., Maréchal, R., Degré, D., Demetter, P., de Nadai, P., Geerts, A., Quertinmont, E., Vercruysse, V., et al. (2009) · Hepatology · doi:10.1002/hep.22680 · Cited by 394
Cited by
Items 201–300 of 302
Exploring the pathogenesis and immunological profiles of psoriasis complicated with MASLD
Tan, S., Liu, M., Feng, F., Li, R., Tian, R., & Nie, Z. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305217 · Cited by 12
Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice
Liu, S.-Y., Huang, C., Yang, Y., Huang, S., Lee, T.-Y., Li, T., Hou, M., & Lin, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276717 · Cited by 10
Yoshikawa, S., Taniguchi, K., Sawamura, H., Ikeda, Y., Asai, T. T., Tsuji, A., & Matsuda, S. (2023) · Livers · doi:10.3390/livers3010002 · Cited by 9
The role of dendritic cells in MASH: friends or foes?
Pinto, A. T., & Lukacs‐Kornek, V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1379225 · Cited by 11
Chen, J., Rao, H., & Zheng, X. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1464865 · Cited by 10
Rahman, A. T., Choi, J., Kyung, W., Kang, S., Lee, S., & Jon, S. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123576 · Cited by 11
Macrophage-tregs crosstalk: the “hub” of the immune network in MASLD
Zhao, H., Wang, W., Zhu, P., & Shi, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680878 · Cited by 13
Li, B., Su, R., Yan, H., Liu, J., Gao, C., Li, X., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907729 · Cited by 9
Saga, A., Koseki, M., Kanno, K., Chang, J., Higo, T., Okuzaki, D., Okada, T., Inui, H., Asaji, M., Tanaka, K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415855 · Cited by 9
“Given that a higher frequency of Th17 cells was previously reported in the livers of nonalcoholic steatohepatitis patients [33], we used FACS to investigate whether the Th17 cell fraction was higher in the blood of this mouse model.”
Vujović, A., Isakovic, A. M., Misirlić‐Denčić, S., Juloski, J. T., Mirković, M., Cirkovic, A. M., Djelic, M. N., & Milošević, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512483 · Cited by 10
“have shown that in NASH patients, levels of IL-6 are increased in comparison with a healthy group [45].”
BackgroundSupruniuk, E., Grubczak, K., Parfieniuk‐Kowerda, A., Flisiak, R., Moniuszko, M., Jaroszewicz, J., Chabowski, A., & Świderska, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1597204 · Cited by 11
Yu, Y., Shi, X., Wang, X., Zhang, P., Bai, O., & Li, Y. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00763-0 · Cited by 8
“In NASH, chronic liver inflammation causes lipolysis and excessive free fatty acids (FFAs) which are associated with hepatic infiltration of T helper 17 (Th17) cells [148] which mediate the progression from NASH to HCC [149, 150].”
BackgroundThe Roles of T Cells in the Development of Metabolic Dysfunction‐Associated Steatohepatitis
Ge, Z., Wu, Q., Lv, C., & He, Q. (2025) · Immunology · doi:10.1111/imm.13943 · Cited by 8
The impact of T cells on immune-related liver diseases: an overview
Koda, Y., Kasuga, R., Taniki, N., Kanai∥, T., & Nakamoto, N. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00387-0 · Cited by 11
“In the MASH, analyses of patients with metabolic dysfunction-associ-ated steatotic liver disease (MASLD) have reported an increase in Th1 cells in the blood [62].”
MASLD: insights on the role of folate in hepatic lipid metabolism
Yang, M., Xiao, X., Mei, J., Pu-Bu-Ci-Ren, & Gong, Q. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1583674 · Cited by 12
HIVEP1 aggravates NASH by reprogramming polyamine metabolism in T H 17 cells
Ren, Y., Liu, X., Feng, M., Zhao, J., Duan, Y., Dong, G., Gao, H., Hao, X., Wang, Q. L., Yao, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adn1150 · Cited by 11
Kado, A., Tsutsumi, T., Yotsuyanagi, H., Ikeuchi, K., Okushin, K., Moriya, K., Koike, K., & Fujishiro, M. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02038-y · Cited by 8
“Th17 cells are important in the inflammatory processes characterizing NASH [56, 57].”
BackgroundObesity-associated Inflammation and Alloimmunity
Zhou, H., Gizlenci, M., Xiao, Y., Martin, F., Nakamori, K., Zicari, E. M., Sato, Y., & Tullius, S. G. (2024) · Transplantation · doi:10.1097/tp.0000000000005183 · Cited by 9
“71 Suppression of intrahepatic Th17 cells, in turn, has been shown to overcome insulin resistance and nonalcoholic steatohepatitis in experimental systems.”
Kandhi, R., Variya, B. C., Ramanathan, S., & Ilangumaran, S. (2022) · The Anatomical Record · doi:10.1002/ar.25039 · Cited by 7
Ickrath, P., Kleinsasser, N. H., Ding, X., Ginzkey, C., Beyersdorf, N., Kerkau, T., Hagen, R., & Hackenberg, S. (2018) · Clinical and Experimental Otorhinolaryngology · doi:10.21053/ceo.2017.01389 · Cited by 7
Self-citationLiang, H., Zhang, D., Wei, N., Xi, P., Ge, H., & Zhang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1652996 · Cited by 8
The Role of CD4+T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Miao, Y., Li, Z., Feng, J., Lei, X., Shan, J., Qian, C., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136895 · Cited by 12
“The proportion of Th2 cells out of the total number of CD4 + T cells is also more highly enriched in the liver tissue than in the blood of NASH and NAFLD patients, with no difference observed between these patients, suggesting an important role of Th2 in NASH and NAFLD progression [36].”
BackgroundHupa‐Breier, K. L., Schenk, H. J., Campos-Murguía, A., Wellhöner, F., Heidrich, B., Dywicki, J., Hartleben, B., Böker, C., Mall, J. W., Terkamp, C., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102104 · Cited by 8
“The signi fi cant increase in T regs may re fl ect an imbalance between pro-in fl ammatory and regulatory T cells, which is associated with progression from simple steatosis to MASH [63] and is also a risk factor for the development of hepatocellular carcinoma [64].”
Xie, H., Wang, J., & Zhao, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-86397-x · Cited by 9
“Rau et al. reported an increase in peripheral Th2 cells in MASH patients compared to healthy controls with normal body weight; however, there were differences in age among the patients 50 .”
Role of CD4+ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases
Seike, T., Mizukoshi, E., & Kaneko, S. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.46 · Cited by 6
Su, S.-B., Chen, W., Huang, F., & Zhang, J. (2018) · European Journal of Inflammation · doi:10.1177/2058739218802678 · Cited by 6
The OGT–TFF2 axis mediates intrahepatic crosstalk and MASH pathogenesis
Zhang, L., Han, C., Shrestha, M. M., Le, J., Berger, W. K., Huang, Y., Desrouleaux, R., Wang, E., Nagy, L., & Yang, X. (2025) · Hepatology · doi:10.1097/hep.0000000000001445 · Cited by 8
Li, D., & Zhang, X. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000846 · Cited by 10
“[118] 125] Given the complexity of immune response to metabolic changes and the challenges in detection approaches, more efforts should be made to explore the specific metabolites or proteins produced by immune cells during MASLD pathogenesis.”
Jiang, S., Feng, J., Jiang, Y., Lü, Z., Kong, J., Li, X., Lian, H., Zhang, F., Li, J., & Li, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111206 · Cited by 7
Kanmani, P., Villena, J., Lim, S.-K., Song, E., Nam, Y., & Kim, H. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400227 · Cited by 6
Yu, R., Huang, Y., Hu, X., & Chen, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32783 · Cited by 7
“In contrast, studies of human hepatic steatosis have shown increased numbers of hepatic Treg cells, albeit indirectly [33 – 38].”
BackgroundResultHo, H.-T., Shih, Y., Huang, T., Fang, W., Liu, C.-H., Lin, J., Hsiang, C., Chu, K., Hsiong, C.-H., Chen, G.-J., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05686-7 · Cited by 6
Heitmann, J., Frings, V. G., Geier, A., Goebeler, M., & Kerstan, A. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14425_g · Cited by 5
Self-citationJiang, S., Jiang, Y., Feng, J., Hou, J., Qin, Z., Wang, Y., Yang, K., & Li, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114300 · Cited by 6
Isbell, M., Mirshahi, F., Aqbi, H. F., Guo, C., Saneshaw, M., Koelsch, N. J., Idowu, M. O., Austin, D., Gelber, C., Wang, X., et al. (2022) · Cancers · doi:10.3390/cancers14225502 · Cited by 5
Childhood Adiposity Associated With Expanded Effector Memory CD8+ and Vδ2+Vγ9+ T Cells
Looman, K. I. M., Santos, S., Moll, H. A., Leijten, C. W. E., Großerichter-Wagener, C., Voortman, T., Jaddoe, V. W. V., van Zelm, M. C., & Jong, J. C. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab433 · Cited by 7
“Further studies are needed because conflicting results about Th17 are present, as there are also studies that have shown increased circulating Th17 in adult patients with NAFLD (56).”
BackgroundResultChaudhary, S., Rai, R., Pal, P., Tedesco, D., Singhi, A., Monga, S. P. S., Grakoui, A., Iyer, S. S., & Raeman, R. (2023) · bioRxiv · doi:10.1101/2023.03.23.533977 · Cited by 2
“Clinical studies in NAFLD patients have yielded conflicting results linking both enrichment and decrease in Tregs in the liver and peripheral blood with disease severity.(11-16) In mouse models where high fat, high fructose, and high cholesterol (Western diet, WD) diet was used to induce NAFLD, most studies reported e…”
ResultImmunology and treatments of fatty liver disease
Tang, S., Wu, S., Zhang, W., Ma, L., Zuo, L., & Wang, H. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03920-1 · Cited by 6
“Compared to WT mice, IFN-γ-deficient mice exhibit less liver steatosis and reduced fibrosis (Inzauga-rat et al. 2011; Rau et al. 2016).”
From model to man: Understanding Tregs' dual role in MASLD
Dywicki, J., Buitrago‐Molina, L. E., Baumann, A. K., Davalos‐Misslitz, A. C. M., Hendriks, C. M., Hupa‐Breier, K. L., Lieber, M., Schlué, J., Blüher, M., Bantel, H., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101619 · Cited by 8
“9,10,35 Notably, intrahepatic accumulation of T H 17 cells was observed even when the total number of CD4 + T cells decreased.”
Self-citationYuan, Y., Hu, J., Lu, X., Han, H., Wang, M., Zhang, W., Yao, J., Li, Y., Lin, Z., Liang, C., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157409 · Cited by 4
Sokal-Dembowska, A., Ergan, K., & Jarmakiewicz-Czaja, S. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i40.111375 · Cited by 5
“In addition, it has been observed that progression of MASLD to MASH is characterised by an increase in IL-17A-producing cells in intrahepatic cluster of differentiation 4 + T cells and a higher Th17/Treg ratio in the peripheral blood[38].”
Chen, Y., Jia, B., Tong, X., Yin, S., Ni, W., Zhao, Q., Shi, J., & Li, J. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000864 · Cited by 6
“[23] IL-17A fuels MASH pathogenesis through key interconnected mechanisms, inducing neutrophil infiltration into white adipose tissue to promote adipose tissue inflammation, insulin resistance, and fatty acid release, which subsequently drive hepatic triglyceride accumulation.”
InfluentialMartínez‐López, S., Ángel‐Gomis, E., Gómez‐Hurtado, I., Fernández‐Iglesias, A., Morante, J., Gracia‐Sancho, J., Boix, P., Cubero, F. J., Zapater, P., Caparrós, E., et al. (2024) · Liver International · doi:10.1111/liv.15836 · Cited by 4
A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization
Ma, W.-T., Liu, Q.-Z., Yang, J.-B., Yang, Y., Zhao, Z.-B., Ma, H.-D., Gershwin, M. E., & Lian, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-15661-6 · Cited by 4
Sbierski‐Kind, J., Cautivo, K. M., Wagner, J. C., Dahlgren, M. W., Nilsson, J., Krasilnikov, M., Mroz, N. M., Lizama, C. O., Gan, A. L., Matatia, P. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.26.537913 · Cited by 5
Martínez‐López, S., Juanola, O., Gómez‐Hurtado, I., Ángel‐Gomis, E., Boix, P., Fernández‐Iglesias, A., Gallardo-Cruz, A., Cubero, F. J., Gracia‐Sancho, J., Puig‐Kröger, A., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101482 · Cited by 4
“…the progression from metabolic dysfunction-associated steatotic liver disease (MASLD) to metabolic dysfunction-associated steatohepatitis (MASH) in patients with MASLD, 6 and with the progression of chronic liver disease and the activation of profibrotic pathways in patients with HBV infection.”
Sbierski‐Kind, J., Cautivo, K. M., Nilsson, J., Wagner, J., Dahlgren, M. W., Ewing-Crystal, N. A., Krasilnikov, M., Mroz, N. M., Ganslmeier, M., Lizama, C. O., et al. (2026) · Science Advances · doi:10.1126/sciadv.aea6805 · Cited by 3
“…that genetic ablation of IL-17A–producing cells reduced the degree of CCl 4 - induced liver fibrosis, in line with previous studies ( 16 , 74 , 88 ), we did not identify a unique contribution of individual cytokines (e.g., IL-17A and IL-22) or T3L sub-sets (e.g., γδ T cells, CD4 + T H 17…”
The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction
González-Serrano, S., Onoiu, A.-I., Jiménez-Franco, A., Cambra-Cortés, V., Camps, J., & Joven, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1797949 · Cited by 4
“Finally, in advanced phases, the diseased liver acquires a fi brogenic architecture, re fl ecting both the cumulative damage from earlier stages and a more predominant adaptive immune response, mainly involving pro-fi brogenic CD4 + T-cell subsets and cytotoxic CD8 + T-cell populations (42, 43).”
Relationship between alanine and aspartate transaminases (ALT and AST) and fatty liver on ultrasound
Khan, A., Ali, S., Haq, M. U. U., Sultan, M., Maqsood, S., & Akhtar, S. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs211571610 · Cited by 3
“Liver enzymes are neither sensitive nor specific for diagnosis of NAFLD 15,16 .”
BackgroundCarrascosa, J. M., Puig, L., Romero, I. B., Salgado‐Boquete, L., del Alcázar, E., Lencina, J. J. A., Moreno-Ramírez, D., & de la Cueva, P. (2022) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2022.01.040 · Cited by 10
Niedecker, R. W., Delaney, J. A., Doyle, M. F., Sparks, A. D., Sitlani, C. M., Bůžková, P., Zeb, I., Tracy, R. P., Psaty, B. M., Budoff, M. J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1243526 · Cited by 3
“These null results are consistent with some prior hepatology clinical studies (18, 19, 41), but not all (37).”
ResultRose, S., Landes, R. D., Vyas, K. K., Delhey, L. M., & Blossom, S. J. (2024) · Immunometabolism · doi:10.1097/in9.0000000000000040 · Cited by 5
“Tregs, anti-inflammatory immune cells, are documented to be reduced in adults with obesity [9,10] and associated with the development of insulin resistance, type 2 diabetes, and fatty liver disease [26–28] .”
BackgroundNonalcoholic Fatty Liver Disease
Alazawi, W., & Hirschfield, G. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_21 · Cited by 3
Rodríguez, E., Simon, P., Dhooge, S., Fernandez, M., Calafat, P., Kurpis, M., Núñez, N. G., Prieto, J. E., Saborowski, A. L., Vogel, A., et al. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.70159 · Cited by 3
“Inflammatory CXCR6 + CD4 + T cells respond to microbiota changes, possibly increasing hepatic IL‐17A secretion [22] and tissue damage that promotes MASH pathogenesis [25].”
Identification and Validation of Hub Immune-Related Genes in Non-Alcoholic Fatty Liver Disease
Li, J., Kou, C., Sun, T., Liu, J., & Zhang, H. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s413545 · Cited by 2
“Since regulatory T cells and Th17 cells represent the two extremes of the immune response (tolerance and inflammation), it has been suggested that NAFLD progression may be associated with disruption of this balance.(25) Our data showed that the infiltration levels of helper T cells and Tfh cells were decreased in NAFL…”
ResultYu, J. H. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0048 · Cited by 2
“In addition, macrophage activity mediated by IFNγ has been described as an important mechanism for the development of non-alcoholic steatohepatitis (NASH).(9,10) In this paper, however, the link between TLR9 and IFNγ is somewhat unclear.”
BackgroundEvaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis
Hildenbrand, F. F., Illi, B., von Felten, S., Bachofner, J., Gawinecka, J., von Eckardstein, A., Müllhaupt, B., Mertens, J. C., & Bluemel, S. (2024) · BMC Gastroenterology · doi:10.1186/s12876-023-03116-4 · Cited by 1
“CK-18 levels are elevated in the presence of necrosis and apoptosis in liver disease [28] with high levels of CK-18 being present in patients with non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and chronic hepatitis C (CHC) [27, 28].”
BackgroundLee, J., Baek, C. H., Kim, S. B., & Jung, C. (2025) · American Journal of Nephrology · doi:10.1159/000542914 · Cited by 1
Mai, M., Wang, Y., Wang, D., Ruan, Y., Mo, B., Li, Z., & Guo, H. (2025) · Hepatitis Monthly · doi:10.5812/hepatmon-157416 · Cited by 4
Mycobiome dysbiosis and genetic predisposition to elevated IL-17A contribute to fibrosis in MASLD
Thielemann, N., Siliceo, S. L., Rau, M., Schöninger, A., Reus, N., Aldejohann, A. M., Shehata, A., Behr, I. S., Nieuwenhuizen, N. E., Herz, M., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101721 · Cited by 5
“To provide evidence for intrahepatic consequences of gut mycobiome dysbiosis, we correlated liver IL-17A levels available from our previous study 6 with the abundance of the most prevalent CTG species, C. albicans and D. hansenii , obtained in the current study (Fig.”
Self-citationChaudhary, S., Rai, R. P., Pal, P. B., Tedesco, D., Rossmiller, D., Gupta, B., Singhi, A. D., Monga, S. P., Grakoui, A., Iyer, S. S., et al. (2026) · Cells · doi:10.3390/cells15020165 · Cited by 9
Abdelnabi, M. N., Maali, Y., Dabbaghizadeh, A., Mokariasl, N., Dion, J., Yamak, R., Soucy, G., Hassan, G. S., & Shoukry, N. H. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf332 · Cited by 1
Chng, W. Q., Liew, J. J., Liew, C. F., Muthiah, M., Zheng, M., & Oon, H. H. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1831174 · Cited by 1
“Interestingly, Th17 cell count decreases signi fi cantly 12 months after bariatric surgery (19) in humans.”
Immune cell balance as potential biomarker of progressing non-alcoholic fatty liver disease
Topchieva, L. V., Валерьевна, К. И., Дуданова, О. П., Vasileva, A., & Жулай, Г. А. (2024) · Genes and Cells · doi:10.17816/gc610252 · Cited by 2
Vizioli, G., Nicoletti, A., Daniela, F., Funaro, B., Verme, L. Z. D., Ponziani, F. R., Zocco, M. A., Gasbarrini, A., & Gabrielli, M. (2025) · Applied Sciences · doi:10.3390/app15052279 · Cited by 3
Aspects immuno-inflammatoires de la stéatohépatite métabolique
Blanc, M., & Gautier, E. L. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.03.012 · Cited by 1
RORγ Structural Plasticity and DruggabilityPreprint
Huang, M. S., Bolin, S., Miller, H., & Ng, H. L. (2020) · Preprints.org · doi:10.20944/preprints202006.0213.v2
Mycobiome Dysbiosis and Genetic Predisposition for Elevated IL-17A Drive Fibrosis in MASLDPreprint
Thielemann, N., Siliceo, S. L., Rau, M., Schoeninger, A., Reus, N., Aldejohann, A., Shehata, A., Behr, I. S., Nieuwenhuizen, N., Herz, M., et al. (2024) · medRxiv · doi:10.1101/2024.10.21.24315902 · Cited by 3
Self-citationKanmani, P., Villena, J., Lim, S.-K., Song, E.-J., Nam, Y.-D., & Kim, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1644742/v1 · Cited by 1
Sharma, P. K., Kumar, L., Baghel, A., Jana, P., Dhar, K., Bansal, R., Goswami, Y., Kumari, A., Yadav, R., Shalimar, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.25.701562 · Cited by 1
González‐Reimers, E., Martín-González, C., Quintero‐Platt, G., Romero-Acevedo, L., & Pérez‐Hernández, O. (2017) · Archives of Hepatitis Research · doi:10.17352/ahr.000010
Nichtalkoholische Fettleber — eine unterschätzte Erkrankung?
Weiß, J., & Geier, A. (2018) · CardioVasc · doi:10.1007/s15027-018-1238-x
“Dass das Darmmikrobiom eine wesentliche Rolle für die Aufnahme von Energieträgern aus der Nahrung spielt und wohl auch Entzündungszellen in der Darmwand aktiviert, die zur Steatohepatitis beitragen, ist zunehmend klar [12] (Abb.”
BackgroundSelf-citationBariatric Surgery in Obese Patients With Psoriasis and COPD
Vita, V. D., & Hansen, P. R. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.04.034
Transcriptional control of cells by vitamin D and its role in liver health and disease
Jahn, D., & Geier, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811907-5.00030-0
Self-citationGulubova, M. V., Hadzhi, M., Hadzhilieva, L., Chonov, D. C., & Ignatova, M. (2021) · Acta Medica Bulgarica · doi:10.2478/amb-2021-0037
Suicide attack: weapon of the weak or crime against humanity?
Ali, M. Y. (2009)
Goto, T., & Hasegawa, K. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.04.035
Weiskirchen, R., & Tacke, F. (2022) · Springer eBooks · doi:10.1007/978-3-662-62484-5_7
Barros, C. D. C. O. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2024.tde-11042024-112641 · Cited by 1
Maali, Y., Fabre, T., & Shoukry, N. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00088-0
Du, J., Zhang, K., Miao, J., Yang, Y., Tian, Y., Wu, T., Tao, C., Wang, Y., & Yang, S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123337 · Cited by 1
Research Progress on the Correlation between Lymphocytes and Non-Alcoholic Fatty Liver Disease
肖, 传. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151095
The Roles of T Lymphocyte Subsets in the Pathogenesis of NAFLD
许, 琳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151105
Zhou, D., Zhang, C., Zhang, L., Jia, J., Fu, J., & Cao, Z. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1546182 · Cited by 2
Monteiro, L. D. B., Bieerkehazhi, S., Aijaz, A., Knuth, C. M., Rix, G., Lee, J. H., Sung, H., Farahat, M., & Jeschke, M. G. (2025) · Shock · doi:10.1097/shk.0000000000002608
Jon, S., Rahman, A. T., Choi, J., Kyung, W., Kang, S., & Lee, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5244382
Kurajoh, M., Fukumoto, S., Akari, S., Nakamura, T., Miki, Y., Nagata, Y., Morioka, T., Mori, K., Imanishi, Y., Watanabe, T., et al. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100374
Dietary salt intake worsens the Th17-dependent inflammatory profile of patients with cirrhosis
Tzoumpa, A., Lozano‐Ruiz, B., Huang, Y., Picó, J., Moratalla, A., Pomares, M. T., Herrera, I., Lozano, J. J., Rodríguez, M., Miralles, C., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.191354
“Finally, several studies have described the pathogenicity of Th17 cells in the progression of metabolic dysfunction–associated steatotic liver disease (MASLD) (9–11).”
The influence of the immune response on liver fibrosis progression in chronic liver diseases
Vujović, A., Milošević, I., & Djelic, M. N. (2025) · Medicinski podmladak · doi:10.5937/mp76-48987
Yang, Y., Wang, N., Chen, Y., Ma, T., Weng, M., Wu, H., Wu, Q., Xie, Y., Zhu, C., & Li, W. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110560
“The liver inflammation during the development of NASH is related to the differentiation of T cells into Th17 cells (9).”
Immune metabolic changes identify causal candidate genes and enable diagnostic frameworks in MAFLD
Qiao, J., Wu, Y., Wang, Y.-Y., Huang, J., & Shan, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-17406-2 · Cited by 1
Zhao, S., & Gan, J. (2025) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2025.09.003
Fleissner, J., Rocca, Y., Freund, L., Ossner, T., Imdahl, F., Doucet-Ladevèze, R., Kurz, F., Geier, A., Goebeler, M., Gasteiger, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.22.695890 · Cited by 1
Self-citationIL - 17 et réponse inflammatoire systémique : focus sur le foie et le muscle
Beringer, A. (2018) · theses.fr (ABES) · doi:10.70675/2d9a348ez5879z4d92z938fz1e4047d398bc
Role of RIPK1 in the survival and death of hepatocytes : its involvement in murine hepatitis models
Farooq, M. (2019) · theses.fr (ABES) · doi:10.70675/5fe7950dz1147z4d64z9b9bz87bfd1d3ae35
Rôle de REG3A dans la maladie métabolique du foie d'origine nutritionnelle
Nguyen, T.-S. (2024) · theses.fr (ABES) · doi:10.70675/2c0ffdcfz96ccz43b0z8e03zb358f83e528d
Subramaniam, N., Gagnon, N., Guilbert, C., Perinpanathan, R., Abraham, M., Gonçalves, C., Meliker, J. R., del Rincón, S., & Mann, K. K. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag073
“Among CD4 þ T cell subsets, Th1 (Kremer et al. 2006) and Th17 cells drive inflammation (Rau et al. 2016; Moreno-Fernandez et al. 2021), whereas Th2 cells are linked to profibrogenic responses (Gieseck et al. 2018).”
The Oral‐Hepatic Axis: Epidemiological and Mechanistic Links Between Periodontal and Liver Diseases
Sahingur, S. E., Grzech‐Leśniak, K., Suslavich, S. F., & Deeb, J. G. (2026) · Journal of Periodontal Research · doi:10.1111/jre.70159
Sawada, K., Oates, J. R., Kimura, M., Stankiewicz, T. E., Eom, J., Alarcon, P. C., Chung, H., Damen, M. S. M. A., Ulanowicz, C. J., Wayland, J. L., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.08.018 · Cited by 1
Russi, A. E., & DeBosch, B. J. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101899
Metadata
- Authors
- Rau, M., Schilling, A.-K., Meertens, J., Hering, I., Weiss, J., Jurowich, C., Kudlich, T., Hermanns, H. M., Bantel, H., Beyersdorf, N., & Geier, A.
- Affiliations
- Universitätsklinikum Würzburg (DE)
- Medizinische Hochschule Hannover (DE)
- University of Würzburg (DE)
- Corresponding author
- Rau, Monika
- Meertens, Jan
- Hering, Ilona
- Weiss, Johannes
- Kudlich, Theodor
- Geier, Andreas
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-01
- Volume
- 196
- Issue
- 1
- Pages
- 97-105
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2219561900
- Cited by
- 302
- References
- 30
- Citations by year
- 2026: 14 · 2025: 54 · 2024: 33 · 2023: 34 · 2022: 40 · 2021: 46 · 2020: 29 · 2019: 13 · 2018: 18 · 2017: 11 · 2016: 9
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, disease progression, Th17 cells, regulatory T cells, IL-17, CD4+ T cells, Th1/Th2 balance, intrahepatic lymphocytes, bariatric surgery, liver inflammation
- MeSH terms
- Adult, Animals, Cells, Cultured, Female, Humans, Interferon-gamma, Liver, Male, Middle Aged, Prospective Studies, Interleukin-4, Th2 Cells, Disease Progression, Lymphocyte Count, Interleukin-17, Bariatric Surgery, T-Lymphocytes, Regulatory, Mice, Th17 Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.